Daphne A. Haas‐Kogan

15.6k citations

206 papers · 7.8k indexed · 4 hit papers · h-index 43

Molecular Biology top 2%
Genetics top 0.2%
Neurology top 0.2%
Cancer Research top 0.5%
Pulmonary and Respiratory Medicine top 1%

Co-authors: David Stokoe Katherine K. Matthay Wendy B. London Robert C. Seeger Michael D. Prados Judith G. Villablanca C. Patrick Reynolds Mitchel S. Berger
Topics: Glioma Diagnosis and Treatment (114 papers)Neuroblastoma Research and Treatments (65 papers)Brain Metastases and Treatment (45 papers)
Cited by: Genetics Neurology Cancer Research
Journals: The Lancet JAMA Nature Communications
Partner nations: United States Canada Netherlands

In The Last Decade

Daphne A. Haas‐Kogan

190 papers receiving 7.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Loss of PTEN facilitates HIF-1-mediated gene expression

2000 688 citations Daphne A. Haas‐Kogan et al. profile →
Long-Term Results for Children With High-Risk Neuroblastoma Treated on a Randomized Trial of Myeloablative Therapy Followed by 13-cis-Retinoic Acid: A Children's Oncology Group Study

2009 621 citations Katherine K. Matthay, C. Patrick Reynolds et al. profile →
Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study

2017 500 citations Daniel Cagney, Eudocia Q. Lee et al. Neuro-Oncology profile →
Effect of Tandem Autologous Stem Cell Transplant vs Single Transplant on Event-Free Survival in Patients With High-Risk Neuroblastoma

2019 214 citations Julie R. Park, Susan G. Kreissman et al. profile →

Peers

Countries citing papers authored by Daphne A. Haas‐Kogan

Since Specialization

Citations

This map shows the geographic impact of Daphne A. Haas‐Kogan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daphne A. Haas‐Kogan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daphne A. Haas‐Kogan more than expected).

Fields of papers citing papers by Daphne A. Haas‐Kogan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daphne A. Haas‐Kogan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daphne A. Haas‐Kogan. The network helps show where Daphne A. Haas‐Kogan may publish in the future.

Co-authorship network of co-authors of Daphne A. Haas‐Kogan

This figure shows the co-authorship network connecting the top 25 collaborators of Daphne A. Haas‐Kogan. A scholar is included among the top collaborators of Daphne A. Haas‐Kogan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daphne A. Haas‐Kogan. Daphne A. Haas‐Kogan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Longitudinal Risk Prediction for Pediatric Glioma with Temporal Deep Learning 2025 ·NEJM AI ·(unknown),(unknown),(unknown),Zezhong Ye,Sridhar Vajapeyam,(unknown),(unknown),(unknown),Ariana Familiar,Tafadzwa L. Chaunzwa,Kevin X. Liu,Sanjay P. Prabhu,Pratiti Bandopadhayay,Ali Nabavizadeh,Sabine Mueller,Hugo J.W.L. Aerts,Daphne A. Haas‐Kogan,Tina Young Poussaint,Benjamin H. Kann	0
2	Case Report: Low-grade glioma with NF1 loss of function mimicking diffuse intrinsic pontine glioma 2024 ·Frontiers in Surgery ·Joshua D. Bernstock,Paramesh Karandikar,Jason Chen,Jakob Seidlitz,Gregory K. Friedman,David M. Meredith,Kevin X. Liu,Daphne A. Haas‐Kogan,David A. Reardon,Pier Paolo Peruzzi	1
3	LGG-15. DEEP LEARNING ENABLES LONGITUDINAL RISK PREDICTION FOR PEDIATRIC LOW-GRADE GLIOMAS AFTER SURGERY 2024 ·Neuro-Oncology ·(unknown),(unknown),(unknown),Zezhong Ye,Sridhar Vajapeyam,(unknown),(unknown),Ariana Familiar,Kevin Liu,Pratiti Bandopadhayay,Ali Nabavizadeh,Sabine Mueller,Hugo J.W.L. Aerts,Daphne A. Haas‐Kogan,Tina Young Poussaint,Benjamin H. Kann	1
4	LGG-05. IMAGING-BASED DEEP LEARNING FOR EVENT-FREE SURVIVAL PREDICTION IN PATIENTS WITH PEDIATRIC LOW-GRADE GLIOMA 2023 ·Neuro-Oncology ·(unknown),(unknown),Zezhong Ye,Sridhar Vajapeyam,(unknown),(unknown),Kevin X. Liu,Hugo J.W.L. Aerts,Pratiti Bandopadhayay,Daphne A. Haas‐Kogan,(unknown),Adam Resnick,Sabine Mueller,Tina Young Poussaint,Tabitha Cooney,Benjamin H. Kann	1
5	Re-irradiation of recurrent IDH-wildtype glioblastoma in the bevacizumab and immunotherapy era: Target delineation, outcomes and patterns of recurrence 2023 ·Clinical and Translational Radiation Oncology ·Sebastian M. Christ,Gilbert Youssef,Shyam Tanguturi,Daniel Cagney,Diana D. Shi,J Ricardo McFaline-Figueroa,Ugonma Chukwueke,Eudocia Q. Lee,Caroline Hertler,Nicolaus Andratschke,Michael Weller,David A. Reardon,Daphne A. Haas‐Kogan,Matthias Gückenberger,Patrick Y. Wen,Rifaquat Rahman	5
6	Serum miRNA-based signature indicates radiation exposure and dose in humans: A multicenter diagnostic biomarker study 2023 ·Radiotherapy and Oncology ·Zuzanna Nowicka,Bartłomiej Tomasik,David Kozono,Konrad Stawiski,Thomas Johnson,Daphne A. Haas‐Kogan,Marek Ussowicz,Dipanjan Chowdhury,Wojciech Fendler	3
7	Patient specific distortion detection and mitigation in MR images used for stereotactic radiosurgery 2022 ·Physics in Medicine and Biology ·Jeremy S. Bredfeldt,(unknown),Evangelia Kaza,(unknown),Martin Requardt,Thorsten Feiweier,Ayal A. Aizer,Shyam Tanguturi,Daphne A. Haas‐Kogan,Rifaquat Rahman,Daniel Cagney,Atchar Sudhyadhom	3
8	Lipidome-based Targeting of STAT3-driven Breast Cancer Cells Using Poly- l -glutamic Acid–coated Layer-by-Layer Nanoparticles 2021 ·Molecular Cancer Therapeutics ·(unknown),Lisa N. Heppler,Susana P. Egusquiaguirre,Natalie Boehnke,Santiago Correa,(unknown),(unknown),Sharmistha Pal,Douglas S. Richardson,Alexander R. Ivanov,Daphne A. Haas‐Kogan,Daniel K. Nomura,Paula T. Hammond,David A. Frank	9
9	Anatomic patterns of relapse and progression following treatment with ¹³¹I‐MIBG in relapsed or refractory neuroblastoma 2021 ·Pediatric Blood & Cancer ·(unknown),Alexei L. Polishchuk,Randall A. Hawkins,Steve Braunstein,Katherine K. Matthay,Steven G. DuBois,Daphne A. Haas‐Kogan	1
10	Race Disparities in High-cost, Limited Resource Cancer Treatment: Proton Radiotherapy Use in Patients Enrolled on Children’s Oncology Group Trials 2020 ·International Journal of Radiation OncologyBiologyPhysics ·Danielle S. Bitterman,Kira Bona,(unknown),(unknown),Stephanie A. Terezakis,Wendy B. London,Daphne A. Haas‐Kogan	2
11	Phase I Clinical Trial of the Wee1 Inhibitor Adavosertib (AZD1775) with Irinotecan in Children with Relapsed Solid Tumors: A COG Phase I Consortium Report (ADVL1312) 2019 ·Clinical Cancer Research ·Kristina A. Cole,Sharmistha Pal,Rachel A. Kudgus,Heba Ijaz,Xiaowei Liu,Charles G. Minard,Bruce Pawel,John M. Maris,Daphne A. Haas‐Kogan,Stephan D. Voss,Stacey L. Berg,Joel M. Reid,Elizabeth Fox,Brenda J. Weigel	48
12	Cooperative Blockade of PKCα and JAK2 Drives Apoptosis in Glioblastoma 2019 ·Cancer Research ·Robyn A. Wong,(unknown),(unknown),Zhenyi An,Daphne A. Haas‐Kogan,Joanna J. Phillips,Kevan M. Shokat,William A. Weiss,Qi Fan	17
13	Role of the extent of prophylactic regional lymph node radiotherapy on survival in high‐risk neuroblastoma: A report from the COG A3973 study 2019 ·Pediatric Blood & Cancer ·Steve Braunstein,Wendy B. London,Susan G. Kreissman,Judith G. Villablanca,Andrew M. Davidoff,Kenneth B. DeSantes,Robert P. Castleberry,Kevin A. Murray,Lisa Diller,Katherine K. Matthay,Susan L. Cohn,Barry L. Shulkin,Daniel von Allmen,Marguerite T. Parisi,Collin Van Ryn,Julie R. Park,Michael P. LaQuaglia,Daphne A. Haas‐Kogan	9
14	Dual HDAC and PI3K Inhibition Abrogates NFκB- and FOXM1-Mediated DNA Damage Response to Radiosensitize Pediatric High-Grade Gliomas 2018 ·Cancer Research ·Sharmistha Pal,David Kozono,Xiaodong Yang,Wojciech Fendler,(unknown),Jing Ni,John A. Alberta,Jean J. Zhao,Kevin X. Liu,Jie Bian,Nathalène Truffaux,William A. Weiss,Adam Resnick,Pratiti Bandopadhayay,Keith L. Ligon,Steven G. DuBois,Sabine Mueller,Dipanjan Chowdhury,Daphne A. Haas‐Kogan	71
15	Phase I study of vorinostat in combination with isotretinoin in patients with refractory/recurrent neuroblastoma: A new approaches to Neuroblastoma Therapy (NANT) trial 2018 ·Pediatric Blood & Cancer ·Navin Pinto,Steven G. DuBois,Araz Marachelian,Scott J. Diede,Agne Taraseviciute,Julia Glade Bender,Denice Tsao‐Wei,Susan Groshen,Joel M. Reid,Daphne A. Haas‐Kogan,C. Patrick Reynolds,Min H. Kang,Meredith S. Irwin,Margaret E. Macy,Judith G. Villablanca,Katherine K. Matthay,Julie R. Park	27
16	Identification of MEK162 as a Radiosensitizer for the Treatment of Glioblastoma 2017 ·Molecular Cancer Therapeutics ·Ravi S. Narayan,(unknown),(unknown),(unknown),Tonny Lagerweij,(unknown),(unknown),Jaap van den Berg,Ben J. Slotman,Tom Würdinger,Daphne A. Haas‐Kogan,Lukas J.A. Stalpers,Brigitta G. Baumert,Bart A. Westerman,Jan Theys,Peter Sminia	19
17	BRAF Status in Personalizing Treatment Approaches for Pediatric Gliomas 2016 ·Clinical Cancer Research ·Aleksandra Olow,Sabine Mueller,Xiao-Dong Yang,Rintaro Hashizume,Justin Meyerowitz,William A. Weiss,Adam Resnick,Angela J. Waanders,Lukas J.A. Stalpers,Mitchel S. Berger,Nalin Gupta,C. David James,Claudia Petritsch,Daphne A. Haas‐Kogan	33
18	Vorinostat Increases Expression of Functional Norepinephrine Transporter in Neuroblastoma In Vitro and In Vivo Model Systems 2011 ·Clinical Cancer Research ·Swati S. More,Melissa Itsara,Xiao-Dong Yang,Ethan G. Geier,(unknown),Youngho Seo,Henry F. VanBrocklin,William A. Weiss,Sabine Mueller,Daphne A. Haas‐Kogan,Steven G. DuBois,Katherine K. Matthay,Kathleen M. Giacomini	51
19	p53 Small-Molecule Inhibitor Enhances Temozolomide Cytotoxic Activity against Intracranial Glioblastoma Xenografts 2008 ·Cancer Research ·Eduard B. Dinca,Kan Lu,Jann N. Sarkaria,Russell O. Pieper,Michael D. Prados,Daphne A. Haas‐Kogan,Scott R. VandenBerg,Mitchel S. Berger,C. David James	42
20	Radiation-Induced Caspase-8 Mediates p53-Independent Apoptosis in Glioma Cells 2006 ·Cancer Research ·(unknown),Nannette Jelluma,Xiaodong Yang,(unknown),Nils D. Arvold,Amelia Karlsson,Garret Yount,Tobias B. Dansen,Erich Koller,Daphne A. Haas‐Kogan	53

About Daphne A. Haas‐Kogan

Daphne A. Haas‐Kogan is a scholar working on Genetics, Neurology and Cancer Research, having authored 206 papers that have together received 7.8k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (114 papers), Neuroblastoma Research and Treatments (65 papers) and Brain Metastases and Treatment (45 papers). The work is most often cited by research in Genetics (2.6k citations), Neurology (2.4k citations) and Cancer Research (1.9k citations). Daphne A. Haas‐Kogan has collaborated with scholars based in United States, Canada and Netherlands. Frequent co-authors include David Stokoe, Katherine K. Matthay, Wendy B. London, Robert C. Seeger, Michael D. Prados, Judith G. Villablanca, C. Patrick Reynolds, Mitchel S. Berger, Robert B. Gerbing and Ayal A. Aizer. Their work appears in journals such as The Lancet, JAMA and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact